RUA Life Sciences's market cap is currently £7.91M. The company's EPS TTM is p0.003; its P/E ratio is 38.64; RUA Life Sciences is scheduled to report earnings on July 22, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	£ 2.19M	£ 2.18M	£ 1.63M	£ 1.53M	£ 489.00K
Gross Profit	£ 1.72M	£ 1.43M	£ 1.04M	£ 980.00K	£ 489.00K
Operating Income	£ -1.94M	£ -2.39M	£ -2.43M	£ -1.80M	£ -991.00K
EBITDA	£ -1.57M	£ -1.95M	£ -2.04M	£ -1.28M	£ -703.00K
Net Income	£ -1.44M	£ -2.00M	£ -2.07M	£ -1.45M	£ -816.00K
Balance Sheet
Cash & Short-Term Investments	£ 3.93M	£ 1.48M	£ 2.96M	£ 6.29M	£ 1.98M
Total Assets	£ 8.17M	£ 5.66M	£ 7.63M	£ 10.15M	£ 2.49M
Total Debt	£ 389.00K	£ 475.00K	£ 344.00K	£ 410.00K	£ 0.00
Net Debt	£ -3.54M	£ -1.01M	£ -2.62M	£ -5.88M	£ -1.98M
Total Liabilities	£ 987.00K	£ 864.00K	£ 868.00K	£ 1.65M	£ 219.00K
Stockholders' Equity	£ 7.18M	£ 4.68M	£ 6.58M	£ 8.51M	£ 2.27M
Cash Flow
Free Cash Flow	£ -1.38M	£ -1.62M	£ -3.27M	£ -2.04M	£ -436.00K
Operating Cash Flow	£ -1.33M	£ -1.17M	£ -2.36M	£ -1.42M	£ -431.00K
Investing Cash Flow	£ -85.00K	£ -449.00K	£ -904.00K	£ -943.00K	£ -5.00K
Financing Cash Flow	£ 3.89M	£ 132.00K	£ -66.00K	£ 6.68M	£ 0.00

Currency in GBP

RUA Life Sciences Earnings and Revenue History

Income Statement >

RUA Life Sciences Debt to Assets

Balance Sheet >

RUA Life Sciences Cash Flow

Cash Flow >

RUA Life Sciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing